FIELD: medicine; pharmacology.
SUBSTANCE: invention refers to method of residual lipoproteins producing inhibition by inhibition of HDL cholesteryl aether transport to chylomicron and/or VLDL, including introduction of composition with SeTr-inhibiting activity to patient for treatment of hyperlipidemia, arteriosclerosis or hyper(residual lipoprotein)emy where composition represents S-8{2-([[1-(2-ethylbutyl) cyclohexyl] carbonyl] amino) phenyl}-2-methylpropanethioat or methane sulfonate trans-(4-{[N-(2-{[N'-[3,5-bis(trifluoromethyl)benzyl]-N'-(2-methyl-2H-tetrazolum-5-yl)amino]-methyl}-5-methyl-4-trifluoromethylphenyl)-N-ethylamino] methyl} cyclohexyl) acetic acid, as active component.
EFFECT: improved efficiency of treatment.
8 cl, 2 ex, 10 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| DIBENZYLAMINE COMPOUNDS, PHARMACEUTICAL COMPOSITION AND THERAPEUTIC OR PROPHYLACTIC AGENT BASED ON THEREOF, METHOD FOR TREATMENT OR PROPHYLAXIS OF HYPERLIPIDEMIA OR ARTERIOSCLEROSIS | 2003 |
|
RU2293078C2 |
| SULPHONAMIDE COMPOUNDS POSSESSING TRPM8 ANTAGONIST ACTIVITY | 2012 |
|
RU2563030C2 |
| METHOD FOR PREPARING VORICONAZOLE AND ITS ANALOGUES | 2013 |
|
RU2619928C2 |
| METHOD FORASYMMETRICTRANSFORMATION OF SUBSTITUTED 2H-CHROMENE-3-CARBOXY ACIDS DUE TO DIFFERENTIAL SOLUBILITY | 2020 |
|
RU2792894C2 |
| 2-PHENYLAMINOPYRIMIDINE DERIVATIVES AS LEUCINE-RICH REPEAT KINASE 2 (LRRK2) MODULATORS FOR TREATMENT OF PARKINSON'S DISEASE | 2012 |
|
RU2661197C2 |
| PRODRUG 1,3-DIAMINO-2-HYDROXYPROPANE DERIVATIVES | 2003 |
|
RU2357962C2 |
| QUINOLINE CARBOXAMIDE AND QUINOLINE CARBONITRILE DERIVATIVES AS mGluR2 NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS AND USE THEREOF | 2012 |
|
RU2610262C2 |
| NEW ANTHELMINTIC QUINOLINE-3-CARBOXAMIDE DERIVATIVES | 2017 |
|
RU2772283C2 |
| PHARMACEUTICAL AGENT CONTAINING INHIBITOR OF SODIUM-DEPENDENT PHOSPHATE CARRIER | 2015 |
|
RU2740008C2 |
| HETEROCYCLIC ARYL SULPHONES, SUITABLE FOR TREATING DISORDERS RESPONSIVE TO 5HT RECEPTOR MODULATION | 2007 |
|
RU2451012C2 |
